slbstpharma / SLBST Pharma |

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.slbstpharma.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	SLBST Pharma \|
Description	SLBST is developing a robust therapeutic platform for treatment of endometriosis, based on modulating the inflammatory axis. Our lead candidate (entering Phase 2b trials) is a re-purposing of the well-known immunomodulatory drug HCQ. SLBST has four
Keywords	N/A

Server Information

WebSite	slbstpharma.com
Host IP	35.208.146.231
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

slbstpharma.com Valuation

US$1,274

Last updated: 2023-05-11 21:11:19

slbstpharma.com has Semrush global rank of 0. slbstpharma.com has an estimated worth of US$ 1,274, based on its estimated Ads revenue. slbstpharma.com receives approximately 147 unique visitors each day. Its web server is located in United States, with IP address 35.208.146.231. According to SiteAdvisor, slbstpharma.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,274
Daily Ads Revenue	US$1
Monthly Ads Revenue	US$35
Yearly Ads Revenue	US$423
Daily Unique Visitors	9
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
slbstpharma.com.	A	14399	IP: 35.208.146.231
slbstpharma.com.	NS	86400	NS Record: ns1.siteground.net.
slbstpharma.com.	NS	86400	NS Record: ns2.siteground.net.
slbstpharma.com.	MX	3600	MX Record: 20 alt1.aspmx.l.google.com.
slbstpharma.com.	MX	3600	MX Record: 30 alt2.aspmx.i.google.com.
slbstpharma.com.	MX	3600	MX Record: 10 aspmx.l.google.com.
slbstpharma.com.	TXT	3600	TXT Record: v=spf1 +a +mx +ip4:35.208.77.178 include:_spf.mailspamprotection.com ~all
slbstpharma.com.	TXT	3600	TXT Record: MS=ms19139877

HtmlToTextCheckTime:2023-05-11 21:11:19

top of page Home SLBST PHARMA Developing a first in class, non-hormonal, long-term treatment for endometriosis About SLBST Pharma SLBST is developing a robust therapeutic platform for treatment of endometriosis, based on modulating the inflammatory axis. Our lead candidate (entering Phase 2b trials) is a re-purposing of the well-known immunomodulatory drug HCQ. SLBST has four additional candidates at the pre-clinical stage. SLBST holds issued US and European method-of-treatment patents for “use of HCQ in an amount appropriate to treat endometriosis”. The company anticipates pursuing both composition-of-matter and method-of-treatment patent claims on its successful pre-clinical candidates. Our total addressable market is vast with a significant unmet need. Endometriosis affects one-in-ten women worldwide, including 7.4M women in the US and 13.1M women in Europe. All existing treatments are hormonal, but three-quarters of women surveyed express dissatisfaction. The latest generation

HTTP Headers

HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Mon, 15 Nov 2021 08:29:30 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Location: https://slbstpharma.com/
Host-Header: 8441280b0c35cbc1147f8ba998a563a7
X-HTTPS-Enforce: 1
X-Proxy-Cache-Info: DT:1

HTTP/2 301 
server: nginx
date: Mon, 15 Nov 2021 08:29:30 GMT
content-type: text/html; charset=UTF-8
location: https://www.slbstpharma.com/
x-cache-enabled: False
x-redirect-by: WordPress
x-httpd: 1
host-header: 8441280b0c35cbc1147f8ba998a563a7
x-proxy-cache-info: DT:1

HTTP/2 200 
server: nginx
date: Mon, 15 Nov 2021 08:29:31 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
x-cache-enabled: False
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
x-httpd: 1
host-header: 8441280b0c35cbc1147f8ba998a563a7
x-proxy-cache-info: DT:1

slbstpharma.com Whois Information

Domain Name: SLBSTPHARMA.COM
Registry Domain ID: 2053794306_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-08-03T00:40:26Z
Creation Date: 2016-08-20T00:10:08Z
Registry Expiry Date: 2024-08-20T00:10:08Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS1.USM13.SITEGROUND.BIZ
Name Server: NS2.USM13.SITEGROUND.BIZ
DNSSEC: unsigned
>>> Last update of whois database: 2021-11-15T08:11:06Z <<<

slbstpharma.com valuation and analysis